The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence and clinical impact of BRCA1/2 mutations in patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC).
 
Nieves Martinez Chanza
No Relationships to Disclose
 
Marie Tkint De Roodenbeke
No Relationships to Disclose
 
Laurence Desmyter
No Relationships to Disclose
 
Francoise Wilkin
No Relationships to Disclose
 
Cindy Badoer
No Relationships to Disclose
 
Isabelle Vandernoot
No Relationships to Disclose
 
Guillaume Smits
No Relationships to Disclose
 
Anna Ayako Accarain
No Relationships to Disclose
 
Spyridon Sideris
No Relationships to Disclose
 
Thierry Gil
No Relationships to Disclose
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly
Research Funding - Bristol-Myers Squibb; MSD
 
Thierry Andre Roumeguere
No Relationships to Disclose
 
Anis Hamid
Honoraria - Bayer
Consulting or Advisory Role - MSD